Nova Cannabis Stock Return On Equity
| NVACF Stock | USD 0.81 0.02 2.41% |
Nova Cannabis fundamentals help investors to digest information that contributes to Nova Cannabis' financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Cannabis otc stock.
Nova |
Nova Cannabis OTC Stock Return On Equity Analysis
Nova Cannabis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nova Cannabis Return On Equity | -0.2 |
Most of Nova Cannabis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nova Cannabis has a Return On Equity of -0.1987. This is 99.17% lower than that of the Healthcare sector and significantly lower than that of the Pharmaceutical Retailers industry. The return on equity for all United States stocks is 35.9% lower than that of the firm.
Nova Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Cannabis' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Cannabis could also be used in its relative valuation, which is a method of valuing Nova Cannabis by comparing valuation metrics of similar companies.Nova Cannabis is regarded third in return on equity category among its peers.
Nova Fundamentals
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0287 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 59.13 M | |||
| Shares Outstanding | 57.15 M | |||
| Shares Owned By Insiders | 62.72 % | |||
| Shares Owned By Institutions | 5.20 % | |||
| Price To Book | 0.44 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 134.36 M | |||
| Gross Profit | 24.89 M | |||
| EBITDA | (7.32 M) | |||
| Net Income | (20.61 M) | |||
| Cash And Equivalents | 6.22 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 60.11 M | |||
| Debt To Equity | 1.11 % | |||
| Current Ratio | 1.07 X | |||
| Book Value Per Share | 0.92 X | |||
| Cash Flow From Operations | (9.98 M) | |||
| Earnings Per Share | (0.30) X | |||
| Number Of Employees | 548 | |||
| Market Capitalization | 35.92 M | |||
| Total Asset | 118.7 M | |||
| Z Score | 1.0 | |||
| Net Asset | 118.7 M |
About Nova Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VTSNX | Vanguard Total International | |
| VBTIX | Vanguard Total Bond | |
| VMCIX | Vanguard Mid Cap Index | |
| GOOGL | Alphabet Inc Class A | |
| AMZN | Amazon Inc |
Other Information on Investing in Nova OTC Stock
Nova Cannabis financial ratios help investors to determine whether Nova OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Cannabis security.